EQGen’s leadership brings experience in global pharmaceutical development, veterinary medicine, regenerative medicine, clinical operations and commercialization. The team has held leadership positions across established pharmaceutical and animal-health organizations and commercial-stage regenerative medicine companies, providing the capabilities needed to advance an innovative veterinary biologic from development toward the market.

Our core advisors provide experience in biotechnology leadership, clinical operations, regulatory affairs, commercial planning and company development.

Built by Experienced Life-Science and Animal-Health Leaders

Executive Management

  • Founder, President & Chief Medical Officer

    • Former CMO, Imara Therapeutics Inc

    • Extensive clinical experience in bone and cartilage field with 30+ years’ experience in global drug development including executive appointments with Eli Lilly, Wyeth and Pfizer

    • LinkedIn Bio

  • Founder & Chief Executive Officer

    • Tested physician executive and entrepreneur with 28+ years of corporate, legal, regulatory and financial expertise within the life science and healthcare sectors

    • Founder and former CEO of successful, commercial-stage regenerative veterinary and human medicine companies

    • Spearheaded the development, commercialization, and distribution of novel veterinary products used in 40k+ horses and dogs to date

    • Diplomate - American Board of Regenerative Medicine

    • LinkedIn Bio

  • Chief Veterinary Officer

    • Seasoned equine and companion animal global industry executive and Board Certified clinician

    • Former Director, Strategic Development and Innovation - Companion Animal and Equine, Merck Animal Health

    • Distinguished lecturer for owners and veterinarians in North and South America, Australia, and Europe

    • Diplomate - American College of Veterinary Internal Medicine

    • LinkedIn Bio

Core Advisors

    • Seasoned biotech executive and CEO of Tasman Therapeutics Inc

    • Founder and former President & CEO, Revance Therapeutics Inc

    • Board member of multiple biotechs including Galderma, Avava and Rythera

    • Clinical operations expert

    • 25+ years of multi-site clinical practice experience

    • Holds technical service, marketing and consulting positions for multiple companies in human and animal health industries

    • Commercial executive with 30+ years' experience and success in medical device, biotech and life science industries 

    • Corporate and start-up company experience and leadership developing and implementing commercial plans and company road maps globally

    • Clinical operations professional

    • More than 20 years' experience in clinical operations, program management and regulatory affairs

    • Multiple roles as VP Clinical Operations